DRUG (Bright Minds Biosciences) Other Operating Expense: $0.24 Mil (TTM As of Mar. 2026)


DRUG Bright Minds Biosciences Inc DRUG
34 GF Score
Price $77.84
! 2 Warning Signs
View Full Analysis

What is Bright Minds Biosciences Other Operating Expense?

Bright Minds Biosciences DRUG -0.46% 34 Other Operating Expense is $0.24 Mil as of Mar. 2026. GuruFocus rates DRUG with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Bright Minds Biosciences's Other Operating Expense for the three months ended in Mar. 2026 was $0.03 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $0.24 Mil.

Bright Minds Biosciences's quarterly Other Operating Expense increased from Sep. 2025 ($0.09 Mil) to Dec. 2025 ($0.11 Mil) but then declined from Dec. 2025 ($0.11 Mil) to Mar. 2026 ($0.03 Mil).

Bright Minds Biosciences's annual Other Operating Expense increased from Sep. 2023 ($0.14 Mil) to Sep. 2024 ($0.15 Mil) and increased from Sep. 2024 ($0.15 Mil) to Sep. 2025 ($0.21 Mil).

Bright Minds Biosciences Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Bright Minds Biosciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bright Minds Biosciences Other Operating Expense Chart

Bright Minds Biosciences Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Operating Expense
Get a 7-Day Free Trial 0.14 0.18 0.14 0.15 0.21

Bright Minds Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.01 0.09 0.11 0.03
DRUG
34GF Score
Bright Minds Biosciences Inc DRUG
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bright Minds Biosciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.24 Mil mean?
Bright Minds Biosciences (DRUG) has a Other Operating Expense of $0.24 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Bright Minds Biosciences and its competitors.
Is Bright Minds Biosciences' Other Operating Expense too high?
Bright Minds Biosciences' current Other Operating Expense is $0.24 Mil. Overall, Bright Minds Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Bright Minds Biosciences' Other Operating Expense compare to VRTX and REGN?
Bright Minds Biosciences' Other Operating Expense of $0.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Bright Minds Biosciences and its competitors. Bright Minds Biosciences's current Other Operating Expense is $0.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bright Minds Biosciences stock overvalued right now?
Bright Minds Biosciences (DRUG) has a current Other Operating Expense of $0.24 Mil. The current Other Operating Expense is $0.24 Mil. Bright Minds Biosciences' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Bright Minds Biosciences (DRUG), the current Other Operating Expense is $0.24 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bright Minds Biosciences Business Description

Other Exchanges DRUG:Canada
Address 19 Vestry Street, New York, NY, USA, 10013
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
34GF Score

Get the complete analysis for DRUG

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$77.84
Price